NEW YORK – Artiva Biotherapeutics, a San Diego-based developer of cancer cell therapies, launched on Friday with $78 million in Series A financing.
The funding round was led by 5AM Ventures, VenBioPartners, and RA Capital Management.
NEW YORK – Artiva Biotherapeutics, a San Diego-based developer of cancer cell therapies, launched on Friday with $78 million in Series A financing.
The funding round was led by 5AM Ventures, VenBioPartners, and RA Capital Management.
...and receive Weekly News bulletins.
Already have a Precision Oncology News or 360Dx or GenomeWeb account?
Login Now.
Don't have a Precision Oncology News or 360Dx or GenomeWeb account?
Register for Free.